• Program Offerings
• Patient Evaluation Process
• Multidisciplinary Team Members

The Stanford Pulmonary Hypertension Program provides comprehensive diagnostic and therapeutic services to patients with all forms of pulmonary hypertension. Fifteen years ago pulmonary hypertension was considered to be a uniformly progressive and fatal disease. While exciting new treatments have been developed since then, patients with pulmonary hypertension face a truly life-threatening illness. Care is therefore provided by a team of closely coordinated experts in pulmonary hypertension, including physicians, clinical nurse specialists, pharmacists, and social workers skilled in counseling patients facing life-threatening illness.

Linking clinical research and state-of-the-art treatment, Stanford is internationally recognized for excellence in the diagnosis and treatment of patients with cardiopulmonary disease. The first heart-lung transplant in the world was performed at Stanford in a patient with pulmonary hypertension. Since then, cardiologists and pulmonologists at Stanford have been at the forefront of new developments in the treatment of cardiopulmonary disease and in evaluating new pharmacologic agents which offer potentially promising therapeutic benefits. Working in conjunction with the lung and heart-lung transplant program, clinical trials are being conducted,using agents that may function as a bridge to transplantation, or as palliative therapy for patients with severe end-stage pulmonary hypertension who are not appropriate transplant candidates.

The Stanford Pulmonary Hypertension Program provides evaluation and treatment of patients with pulmonary hypertension and offers:

• Consultation with referring physicians
• Treatment alternatives:
  • individualized medical therapy
  • risk assessment
  • access to the most current drug therapies
  • access to clinical trials of investigational drugs
  • surgical interventions: lung and heart-lung transplantation, thromboembolectomy
• Consultation and coordination with other Stanford specialists

Back to the Top

Patient Evaluation Process:

New patient referrals and appointments can be made by calling the Chest Clinic at Stanford: at 650-723-6983 (or 650-725-7061, for all other inquiries). After the initial consultation a faculty physician will contact the referring physician to discuss findings and recommendations. At the request of the referring physician, patients with major symptoms despite empiric therapy may be admitted to the Intensive Care Unit at Stanford. Treatment recommendations and follow-up care are developed through close collaboration with the referring physician.

Back to the Top

Stanford Pulmonary Hypertension Program Multidisciplinary Team Members:

Dr. Ramona Doyle, Director,
Associate Professor of Medicine,
Division of Pulmonary and Critical Care Medicine,
Stanford University Medical Center

Dr. Roham Zamanian
Instructor of Medicine,
Division of Pulmonary and Critical Care Medicine
Stanford University Medical Center

Val Scott, R.N., Nurse Coordinator

Julianna Liu, R.N., Nurse Practitioner

Allyson Rupp, LCSW, Social Worker

For more information about pulmonary hypertension therapies, please see:
Vera Moulton Wall Center Patient Care Overview

Back to the Top